INFUSION SITE REACTION

This adverse event was reported 2990 times

These drugs are most commonly taken by patients reporting INFUSION SITE REACTION:

# Drug Count
0 TREPROSTINIL 652
1 ACETAMINOPHEN 472
2 INFLIXIMAB 429
3 RITUXIMAB 418
4 METHOTREXATE SODIUM 411
5 TOCILIZUMAB 399
6 LEFLUNOMIDE 390
7 ERGOCALCIFEROL 381
8 ABATACEPT 374
9 ACETAMINOPHEN 500MG 373
See all common drugs associated with INFUSION SITE REACTION

INFUSION SITE REACTION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 FOSCARBIDOPA/FOSLEVODOPA 291 0.0330
1 CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE 18 0.0274
2 KETAMINE HYDROCHLORIDE 116 0.0226
3 12%AZELAIC ACID 18 0.0215
4 CORTISONE ACETATE 252 0.0202
5 APOMORPHINE HYDROCHLORIDE 31 0.0184
6 BOTULINUM TOXIN TYPE A 233 0.0182
7 AZELAIC ACID 18 0.0182
8 HYDROCORTISONE BUTYRATE 35 0.0177
9 PSEUDOEPHEDRINE HCL 184 0.0168
See all drugs enriched for association with INFUSION SITE REACTION

INFUSION SITE REACTION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 221 0.3212
1 Human Immunoglobulin G [EPC] 362 0.0172
2 Provitamin D2 Compound [EPC] 381 0.0128
3 Endoglycosidase [EPC] 17 0.0092
4 Interleukin-17A Antagonist [EPC] 313 0.0084
5 Catechol-O-Methyltransferase Inhibitor [EPC] 31 0.0062
6 Vitamin B6 Analog [EPC] 2 0.0055
7 beta3-Adrenergic Agonist [EPC] 251 0.0053
8 Prostacycline Vasodilator [EPC] 654 0.0047
9 Human C1 Esterase Inhibitor [EPC] 18 0.0046
See all drug classes enriched for association with INFUSION SITE REACTION